News

Mytil Suspension :

Mytil Suspension :

16 Mar, 2009

 Mytil, a second generation fluoroquinolone antibacterial, is indicated for the treatment of following infections caused by sensitive bacteria: respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, complicated intra-abdominal infections, infections of the biliary tract, gastrointestinal infections, pelvic inflammatory diseases, severe systemic infections, gonorrhea, complicated urinary tract infections, pyelonephritis and inhalational anthrax in adults. Whereas in children Mytil is indicated for treatment of complicated urinary tract infections, pyelonephritis due to E.coli, infectious diarrhea (Shigellosis), typhoid fever and inhalational anthrax.

Sitemap | Contact Us Copyright © 2017 Wilson's Pharmaceuticals. All Rights Reserved.